Clinical Trials: A Phase II Study of Ferumoxytol and Gadolinium Magnetic Resonance Imaging at 3T and 7T in Patients With Malignant Brain Tumors Either Before or After Therapy

Sponsor and Collaborators

Oregon Health and Science University

National Institute of Neurological Disorders and Stroke (NINDS)

Contact

Edward A Neuwelt, MD

503-494-5626     

neuwelte@ohsu.edu

Nancy A Hedrick, BA

503-494-5626

hedrickn@ohsu.edu

Principal Investigator

Edward A Neuwelt, MD, Oregon Health and Science University

ClinicalTrials.gov Identifier

NCT00659126

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs